On this page: About the National Data | Methodology | History | References
About the National Data
Data
Data Source: United States Renal Data System (USRDS), NIH/NIDDK
Baseline: 36.6 percent of Medicare beneficiaries aged 65 years and over with chronic kidney disease received medical evaluation with serum creatinine, lipids, and urine albumin tests in 2016
Target: 49.5 percent
Methodology
Methodology notes
The data to track this objective come from the USRDS 5% Medicare sample. The USRDS data, data collection procedures, calculation methods, and other technical information are included in the USRDS Annual Data Report.
History
In 2023, the original baseline was revised from 35.9 to 36.6 percent due to USRDS rates re-estimation. There is some lag in reporting new cases of ESRD. Therefore, each year's Annual Data Report includes re-estimates of earlier year rates. For more information see the USRDS Annual Data Reports. The target was adjusted from 48.8 to 49.5 percent to reflect the revised baseline using the original target-setting method.
References
Additional resources about the objective
- United States Renal Data System. 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2018.
1. Because Healthy People 2030 objectives have a desired direction (e.g., increase or decrease), the confidence level of a one-sided prediction interval can be used as an indication of how likely a target will be to achieve based on the historical data and fitted trend.